Everence Capital Management Inc. bought a new position in uniQure (NASDAQ:QURE – Get Rating) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,260 shares of the biotechnology company’s stock, valued at approximately $207,000. A number of other institutional investors have also recently […]
uniQure (NASDAQ:QURE – Get Rating) – Stock analysts at Cantor Fitzgerald cut their FY2023 earnings per share (EPS) estimates for shares of uniQure in a report released on Tuesday, May 16th. Cantor Fitzgerald analyst K. Kluska now expects that the biotechnology company will post earnings per share of ($1.61) for the year, down from their […]
1-800-FLOWERS.COM restated their maintains rating on shares of uniQure (NASDAQ:QURE – Get Rating) in a research note published on Tuesday, Benzinga reports. A number of other equities analysts have also recently commented on the stock. Chardan Capital cut their price target on shares of uniQure from $60.00 to $56.00 in a research note on Wednesday, […]
uniQure (NASDAQ:QURE – Get Rating) – HC Wainwright increased their FY2024 earnings estimates for shares of uniQure in a report released on Thursday, December 15th. HC Wainwright analyst P. Trucchio now expects that the biotechnology company will post earnings of ($1.20) per share for the year, up from their previous estimate of ($1.49). The consensus […]